Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-041156
Filing Date
2024-10-15
Accepted
2024-10-15 17:00:36
Documents
46
Period of Report
2024-08-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 735513
2 ex31-1.htm EX-31.1 8343
3 ex31-2.htm EX-31.2 8306
4 ex32-1.htm EX-32.1 3974
5 ex32-2.htm EX-32.2 3950
  Complete submission text file 0001493152-24-041156.txt   3764086

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE bmra-20240831.xsd EX-101.SCH 22127
7 XBRL CALCULATION FILE bmra-20240831_cal.xml EX-101.CAL 42723
8 XBRL DEFINITION FILE bmra-20240831_def.xml EX-101.DEF 90932
9 XBRL LABEL FILE bmra-20240831_lab.xml EX-101.LAB 226810
10 XBRL PRESENTATION FILE bmra-20240831_pre.xml EX-101.PRE 169286
48 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 534821
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9493792875
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 001-37863 | Film No.: 241372529
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)